Biosyent Inc (BIOYF)
7.49
0.00 (0.00%)
USD |
OTCM |
Jul 01, 16:00
Biosyent Shareholders Equity (Quarterly): 25.57M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 25.57M |
December 31, 2023 | 26.20M |
September 30, 2023 | 25.42M |
March 31, 2023 | 24.71M |
December 31, 2022 | 24.58M |
September 30, 2022 | 24.13M |
June 30, 2022 | 25.40M |
March 31, 2022 | 25.66M |
December 31, 2021 | 24.75M |
September 30, 2021 | 23.78M |
June 30, 2021 | 23.23M |
March 31, 2021 | 21.98M |
December 31, 2020 | 21.01M |
September 30, 2020 | 19.51M |
June 30, 2020 | 18.37M |
March 31, 2020 | 18.09M |
December 31, 2019 | 19.75M |
September 30, 2019 | 19.18M |
June 30, 2019 | 18.89M |
March 31, 2019 | 20.19M |
December 31, 2018 | 20.27M |
September 30, 2018 | 20.55M |
June 30, 2018 | 19.00M |
March 31, 2018 | 18.15M |
December 31, 2017 | 17.66M |
Date | Value |
---|---|
September 30, 2017 | 16.67M |
June 30, 2017 | 14.89M |
March 31, 2017 | 13.29M |
December 31, 2016 | 12.41M |
September 30, 2016 | 11.84M |
June 30, 2016 | 11.00M |
March 31, 2016 | 10.13M |
December 31, 2015 | 8.757M |
September 30, 2015 | 8.439M |
June 30, 2015 | 8.126M |
March 31, 2015 | 7.249M |
December 31, 2014 | 7.029M |
September 30, 2014 | 6.606M |
June 30, 2014 | 5.941M |
March 31, 2014 | 4.926M |
December 31, 2013 | 4.559M |
September 30, 2013 | 4.151M |
June 30, 2013 | 3.495M |
March 31, 2013 | 3.181M |
December 31, 2012 | 2.854M |
September 30, 2012 | 2.324M |
June 30, 2012 | 1.772M |
March 31, 2012 | 1.484M |
December 31, 2011 | 1.139M |
September 30, 2011 | 1.025M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
18.09M
Minimum
Mar 2020
26.20M
Maximum
Dec 2023
22.85M
Average
23.95M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 61.74M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 29.60M |
Total Liabilities (Quarterly) | 4.029M |
Current Ratio | 7.718 |